Here are relevant reports on : car-t-cell-therapy-market
-
Car as a Connected Living Ecosystem - Global Forecast to 2035
By 2035, automotive OEMs can earn up to $1,600 per vehicle annually from digitally connected living services offered through the car. The total market for connected living services is estimated to grow from $8 billion in 2023 to more than $1.5 trillion by 2035 at the CAGR of 54.5%. Major players in the Car as a Connected Living include Mercedez Benz (Germany), BMW (Germany), VW (Germany), Stellantis (Netherlands), Hyundai (South Korea), Toyota (Japan), GM (USA), Ford (USA), Nio (China), Xpeng (China). All OEMs offer vary levels of connectivity solutions through the car.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Global Sports Car Market - Trends and Forecasts 2015-2020
A sports car is a car designed for speed, high acceleration and manoeuvrability and usually adequate for seating only two persons. It is equipped for racing and has steering and suspension designed for precise control at high speeds. With new technological innovations and increase in disposable income of people in developing and developed economies, the demand for sports cars is on the rise. This report covers forecast and analysis for the sports car market on a global level. The study provides forecasts for the period 2015-2020 based on both volume and revenue. The study includes drivers and restraints for the sports car market along with the impact they have on the demand over the forecast period. Additionally, this report includes opportunities available in the market on a global level. The drivers, restraints and opportunities mentioned in the report are justified with the help of qualitative and quantitative data which is verified by primary and secondary resources. The major players in the market are identified and discussed in detail.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Used Car Market 2032: Size, Share & Growth Report
The global used car market was valued at an estimated USD 2.01 trillion in 2025 and is projected to reach USD 3.46 trillion by 2032, growing at a CAGR of 8.0% between 2026 and 2032.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Passenger Car Active & Passive Safety Systems Market - By Type, Technology & Geography (2014 - 2019)
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) & Region - Global Forecast to 2029
The global autologous stem cell & non-stem cell therapies market, valued at US$3.9 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2029, culminating in a forecasted valuation of US$22.2 billion by the end of the period. The major factors driving the growth of this market are the rising regulatory approvals for autologous CAR T cell therapies, increasing R&D investments in autologous therapeutics, and growing demand for personalized medicines.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The North America Cell Culture Market, valued at US$11.10 billion in 2024, stood at US$11.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$20.38 billion by the end of the period. Growth of the North America cell culture market is driven by a strong and expanding biopharmaceutical industry, with rising production of biologics such as monoclonal antibodies, vaccines, and cell-based therapies that rely heavily on advanced culture techniques and systems.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Cartilage Repair Market | Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-Cell (Tissue Scaffolds)), Application (Hyaline, Fibrocartilage), Site, and Region - Global Forecast to 2028
The global cartilage repair market, valued at US$1.1 billion in 2022, stood at US$1.3 billion in 2023 and is projected to advance at a resilient CAGR of 17.2% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. Growth in this market is mainly driven by the Increasing incidence of osteoarthritis, Increasing research funding and investments and the rising number of sports and accident-related orthopedic injuries.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Stem Cell Assays Market Size by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2027
The size of global stem cell assays market in terms of revenue was estimated to be worth USD 1.9 billion in 2022 and is poised to reach USD 4.5 billion by 2027, growing at a CAGR of 17.7% from 2022 to 2027. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Track Etched Membrane Market by Product (Membrane Filter, Capsule & Cartridge Filter, Cell Culture Insert), Material (Polycarbonate, Polyimide), Application (Cell Biology, Microbiology, Analytical testing, Automotive), End User - Global Forecasts to 2023
The track etched membrane market is projected to reach USD 813.1 million by 2023, growing at a CAGR of 11.3%. Key players operating in the global track etched membrane are GE Healthcare (US), Danaher (US), Corning (US), Merck (Germany), it4ip (Belgium), Sterlitech (US), Oxyphen (Switzerland), Sarstedt (US), BRAND GMBH (Germany), Sartorius (Germany), SABEU (Germany), Zefon International (US), GVS (Italy), Thermo Fisher Scientific (US), Eaton (Ireland), Greiner Bio-One (Austria), MACHEREY-NAGEL (Germany), Avanti Lipids Polar (US), SKC (US), Advantec (Canada), Avestin (Canada), Scaffdex (Finland), and Graver Technologies (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Europe Cell Culture Market, valued at US$8.01 billion in 2024, stood at US$8.50 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.23 billion by the end of the period. The growth of the Europe cell culture market is driven by a strong and expanding biopharmaceutical sector, with rising production of biologics such as monoclonal antibodies, vaccines, and recombinant proteins that rely on sophisticated culture systems.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
